LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $172,396 | +6.7% | 2,046 | -7.5% | 0.00% | – |
Q1 2024 | $161,623 | +23.0% | 2,211 | +20.2% | 0.00% | – |
Q4 2023 | $131,412 | +57.8% | 1,840 | +32.4% | 0.00% | – |
Q3 2023 | $83,289 | -25.2% | 1,390 | -10.0% | 0.00% | – |
Q2 2023 | $111,395 | -3.2% | 1,545 | -1.3% | 0.00% | – |
Q1 2023 | $115,120 | +20.1% | 1,565 | +9.1% | 0.00% | – |
Q4 2022 | $95,857 | -12.9% | 1,435 | +13.0% | 0.00% | – |
Q3 2022 | $110,000 | +41.0% | 1,270 | +45.1% | 0.00% | – |
Q2 2022 | $78,000 | -42.2% | 875 | -27.6% | 0.00% | – |
Q1 2022 | $135,000 | -22.9% | 1,208 | +6.5% | 0.00% | – |
Q4 2021 | $175,000 | +24.1% | 1,134 | +12.4% | 0.00% | – |
Q3 2021 | $141,000 | +67.9% | 1,009 | +58.9% | 0.00% | – |
Q2 2021 | $84,000 | -16.8% | 635 | -3.6% | 0.00% | – |
Q1 2021 | $101,000 | +68.3% | 659 | +11.3% | 0.00% | – |
Q4 2020 | $60,000 | -25.0% | 592 | -29.4% | 0.00% | – |
Q3 2020 | $80,000 | -23.8% | 838 | -10.7% | 0.00% | – |
Q2 2020 | $105,000 | +32.9% | 938 | -13.5% | 0.00% | – |
Q1 2020 | $79,000 | -38.8% | 1,084 | -13.1% | 0.00% | – |
Q4 2019 | $129,000 | +19.4% | 1,248 | +14.6% | 0.00% | – |
Q3 2019 | $108,000 | -57.5% | 1,089 | -51.2% | 0.00% | – |
Q2 2019 | $254,000 | +2.0% | 2,232 | +13.3% | 0.00% | – |
Q1 2019 | $249,000 | -5.3% | 1,970 | +1.6% | 0.00% | – |
Q4 2018 | $263,000 | -96.7% | 1,939 | -93.4% | 0.00% | -100.0% |
Q3 2018 | $8,079,000 | -1.5% | 29,439 | -25.6% | 0.01% | 0.0% |
Q2 2018 | $8,199,000 | +25.6% | 39,583 | +0.1% | 0.01% | +33.3% |
Q1 2018 | $6,527,000 | +20.1% | 39,524 | -0.5% | 0.01% | +20.0% |
Q4 2017 | $5,436,000 | +46.4% | 39,705 | +45.6% | 0.01% | +25.0% |
Q3 2017 | $3,713,000 | +206.6% | 27,265 | +173.3% | 0.00% | +300.0% |
Q2 2017 | $1,211,000 | +20.5% | 9,975 | +5.1% | 0.00% | 0.0% |
Q1 2017 | $1,005,000 | -28.4% | 9,492 | -31.3% | 0.00% | -50.0% |
Q4 2016 | $1,403,000 | -24.8% | 13,808 | -24.5% | 0.00% | 0.0% |
Q3 2016 | $1,866,000 | -16.4% | 18,281 | -2.2% | 0.00% | -33.3% |
Q2 2016 | $2,231,000 | +13.1% | 18,694 | +1.5% | 0.00% | +50.0% |
Q1 2016 | $1,973,000 | +44.2% | 18,418 | +45.9% | 0.00% | 0.0% |
Q4 2015 | $1,368,000 | +27.9% | 12,628 | +1.2% | 0.00% | +100.0% |
Q3 2015 | $1,070,000 | -13.3% | 12,479 | +2.0% | 0.00% | 0.0% |
Q2 2015 | $1,234,000 | +65.6% | 12,237 | +26.6% | 0.00% | 0.0% |
Q1 2015 | $745,000 | +90.1% | 9,669 | +31.1% | 0.00% | – |
Q4 2014 | $392,000 | -23.9% | 7,373 | -32.7% | 0.00% | -100.0% |
Q3 2014 | $515,000 | -40.3% | 10,954 | -20.8% | 0.00% | 0.0% |
Q2 2014 | $862,000 | -13.9% | 13,839 | -7.0% | 0.00% | 0.0% |
Q1 2014 | $1,001,000 | +43.6% | 14,880 | +12.3% | 0.00% | 0.0% |
Q4 2013 | $697,000 | -20.4% | 13,255 | -34.5% | 0.00% | 0.0% |
Q3 2013 | $876,000 | 0.0% | 20,232 | -13.6% | 0.00% | 0.0% |
Q2 2013 | $876,000 | – | 23,420 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |